Abstract
It is now generally agreed that the hyperacute rejection (HAR) of pig organs by both human and nonhuman primates is related to the presence of preformed “natural” antibodies in the host [1–4]. The true origin of these antibodies is speculative, but they develop within a few weeks after birth, probably as soon as the neonate’s gastrointestinal tract becomes colonized by microorganisms [5, 6]. The antibody-antigen reaction that takes place on the surface of the vascular endothelium stimulates the complement cascade and “activates” the endothelial cells [7], leading to endothelial cell damage with capillary disruption and interstitial hemorrhage [8], resulting in rapid destruction of the tissues with loss of function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
ROSENBERG, J.C., BROERSMA, R.J., BULLEMER, G., et al. Relationship of platelets, blood coagulation, and fibrinolysis to hyperacute rejection of renal xenografts. Transplantation. 1969, 8, 152
ROSENBERG, J.C., HAWKINS, E., RECTOR, F. Mechanisms of immunological injury during antibody-mediated hyperacute rejection of renal heterografts. Transplantation. 1971, 11, 151
HAMMER, C, CHAUSSEY, C.H., BRENDEL, W. Preformed natural antibodies in animals and man. Outlook on xenotransplantation. Eur. Surg. Res. 1973, 5, 162
HAMMER, C. Isohemagglutinins and preformed natural antibodies in xenogeneic organ transplantation. Transplant. Proc. 1987, 19, 4443
WIENER, A.S. Origin of naturally-occurring hemagglutinins and hemolysins: a review. J. Immunol. 1951, 66, 287
SPRINGER, G.F., HORTON, R.E Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J. Clin. Invest. 1969, 48, 1280
PLATT, J.L., BACH, F.H. Mechanism of tissue injury in hyperacute xenograft rejection. In: Xenotransplantation. (Cooper, D.K.C. et al., eds) Springer, Heidelberg, 1991, p. 69
ROSE, A.G., COOPER, D.K.C, HUMAN, P.A., Reichenspurner, H., Reichart, B. Histopathology of hyperacute rejection of the heart- experimental and clinial observations in allografts and xenografts. J. Heart Lung Transplant. 1991, 10, 223
ALEXANDRE, G.P., SQUIFFLET, J.P., DE BRUYERE, M., et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant. Proc. 1985, 17, 138
ALEXANDRE, G.P.J., SQUIFFLET, J.P., DE BRUYERE, E.M., et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant. Proc. 1987, 19, 4538
BANNETT, A.D., MCALACK, R.F., RAJA, R., BAQUERO, A., MORRIS, M. Experiences with known ABO-mismatched renal transplants. Transplant. Proc. 1987, 19, 4543
COOPER, D.K.C. Depletion of natural antibodies in non-human primates - a step towards successful discordant xenografting in humans. Clin. Transplantation. 1992, 6, 178
COOPER, D.K.C. Is xenotransplantation a realistic clinical option? Transplant. Proc. 1992, 24, 2393
COOPER, D.K.C, YE, Y, KEHOE, M., et al. A novel approach to “neutralization” of preformed antibodies: cardiac allotransplantation across the ABO-blood group barrier as a paradigm of discordant xenotransplantation. Transplant. Proc. 1992, 24, 566
COOPER, D.K.C, YE, Y, NIEKRASZ, M., et al. Specific intravenous carbohydrate therapy - a new concept in inhibiting antibody-mediated rejection: experience with ABO- incompatible cardiac allografting in the baboon. Transplantation. 1993, 56, 769
COOPER, D.K.C, GOOD, A.H., MALCOLM, A.J., et al. Specific intravenous carbohydrate therapy — a new approach to the inhibition of antibody-mediated rejection fol- lowing ABO-incompatible allografting and discordant xenografting. Transplant. Proc. 1993, 25, 377
BACH, F.H., TURMAN, M.A., VERCELLOTTI, G.M., PLATT, J.L., DALMASSO, A.P. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant. Proc. 1991, 23, 205
COOPER, D.K.C Clinical survey of heart transplantation between ABO-blood group incompatible recipients and donors. J. Heart Transplant. 1990, 9, 376
COOK, D.J., GRAVER, B., TERASAKI, P.I. ABO-incompatibility in cadaver donor kid- ney allografts. Transplant. Proc. 1987, 19, 4549
OPELZ, G. Collaborative Kidney Transplant Study Newsletter 2, 1988
GORDON, R.D., IWATSUKI, S., ESQUIVEL, CO., et al. Experience with primary liver transplantation across ABO blood groups. Transplant. Proc. 1987, 19, 4575
COOPER, D.K.C, LEXER, G., ROSE, A.G., et al. Cardiac allotransplantation across major blood group barriers in the baboon. J. Med. Primatol. 1988, 17, 333
COOPER, D.K.C, HUMAN, P.A., LEXER, G., et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J. Heart Transplant. 1988,7,238
ALEXANDRE, G.P.J., GIANELLO, P., LATINNE, D., et al. Plasmapheresis and splenect- omy in experimental renal xenotransplantation. In: Xenograft 25. (Hardy, M.A., ed) New York, Elsevier, 1989, p. 259
FISCHEL, R.J., PLATT, J.L., MATAS, A.J., et al. Prolonged survival of a discordant car diac xenograft in a rhesus monkey. Transplant. Proc. 1991, 23, 589
ROSLIN M.S., ZISBROD, Z., BURACK, J.H., et al. 15-day survival in pig-to-baboon heterotpic cardiac xenotransplantation. Transplant. Proc. 1992, 24, 572
KOBAYASHI, T., TANIGUCHI, S., YE, Y., et al. Delayed xenograft rejection in C3- depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor. Transplant. Proc. In press
WHITE, D.J.G., BRAIDLEY, P., DUNNING, J., et al. Hearts from pigs transgenic for human DAF are not hyper acutely rejected when xenografted to primates. Presented to the Third International Congress for Xenotransplantation. Boston, 1995.
LIOYD, K.O., KABAT, E.A., LICERIO, E. Immunochemical studies on blood groups. 38: Structures and activities of oligosaccharides produced by alkaline degradation of blood-group Lewis-a substance. Proposed structure of the carbohydrate chains of human blood-group A, B, H, Lea, and Leb substances. Biochemistry. 1968, 7, 2976
WATKINS, W.M. Genetic regulation of the structure of blood-group-specific glycoproteins. Biochem. Soc. Symp. 1974, 40, 125
WATKINS, W.M. Biochemistry and genetics of the ABO, Lewis, and P blood group systems. In: Advances in Human Genetics, Vol. 10. Harris, H., Hirschhorn, K. (eds) Plenum, New York, 1980, p. 1
WATKINS, W.M. Biosynthesis. Molecular basis of antigenic specificity in the ABO, H and Lewis blood group systems. In: Glycoproteins, Montreuil, J., Schachter, H., Vligenhart, J.F.G. (eds) Elsevier, Amsterdam, 1995, p. 313
LEMIEUX, R.U. Human blood groups and carbohydrate structures. Chem. Soc. Rev. 1978, 7, 423
PINTO, B.M., BUNDLE, D.R. Preparation of glycoconjugates for use as artificial anti— gens: a simplified procedure. Carbohydrate Res. 1983, 124, 313
BENSINGER, W.I., BAKER, D.A., BUCKNER, CD., CLIFT, R.A., THOMAS, E.D. Immunoadsorption for removal of A and B blood group antibodies. N. Engl. J. Med. 1981, 304, 1360
BENSINGER, W.I., BAKER, D.A., BUCKNER, CD., CLIFT, R.A., THOMAS, E.D. In vitro and in vivo removal of anti-A erythrocyte antibody by adsorption to a synthetic immunoadsorbent. Transfusion. 1981, 21, 335
BENSINGER, W.L, BUCKNER, CD., CLIFT, R.A. Whole blood immunoadsoption of anti-A or anti-B antibodies. Vox. Sang. 1985, 48, 357
ROMANO, E.L., BHARDWAJ, J., KELLY, S., et al. Interaction of IgG and IgM anti-A with synthetic oligosaccharides. Transplant. Proc. 1987, 19, 4479
ROMANO, E.L., SOYANO, A., LINARES, J. Preliminary human study of synthetic trisaccharide representing blood substance A. Transplant. Proc. 1987, 19, 4475
ROMANO, E.L., SOYANO, A., LINARES, J., LAUZON, G.J. Neutralization of ABO blood group antibodies by specific oligosaccharides. Transplant. Proc. 1987, 19, 4426
LAUS, R., ULRICHS, K., MULLER-RUCHHOLTZ, W. Carbohydrate-specific human heterophile antibodies in normal human sera that react with xenogeneic cells. Arch. Allergy Appl. Immun. 1988, 85, 201
PLATT, J.L., LINDMAN, B.J., CHEN, H., SPITALNIK, S.L., BACH, EH. Endothelial cell antigens recognized by xenoreactive human natural antibodies. Transplantation. 1990, 50, 817
HOLGERSSON, J., CAIRNS, T.D.H., BREIMER, M.E., et al. Carbohydrate antigen specificity of pig lymphocytotoxic IgM antibodies produced by 2 EBV transformed human B cell lines. Glycoconjugate J. 1991, 8, 172
GOOD, A.H., COOPER, D.K.C, MALCOLM, A.J., et al. Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant xenografting in man. Transplant. Proc. 1992, 24, 559
COOPER, D.K.C, GOOD, A.H., KOREN, E., et al. Identification of α-galactosyl and other carbohydrates that are bound by human anti-pig antibodies: relevance to discor- dant xenografting in man. Transpl. Immunol. 1993, 1, 198
KOREN, E., NEETHLING, F.A., YE, Y., et al. Heterogeneity of preformed human antipig xenogeneic antibodies. Transplant. Proc. 1992, 24, 598
KOREN, E., NEETHLING, F.A., RICHARDS, S., et al. Binding and specificity of major immunoglobulin classes of preformed human anti-pig heart antibodies. Transplant. Int. 1993, 6, 351
KUJUNDZIC, M., KOREN, E., NEETHLING, R.A., et al. Variability of anti-Gal antibodies in human serum and their relation to serum cytotoxicity against pig cells. Xenotransplantation. 1994, 1, 58
RIEBEN, R., VON ALLMEN, E., KORCHAGINA, E.Y., et al. Detection, immunoadsorption, and inhibition of cytotoxic activity of anti-aGal antibodies using newly developed substances with synthetic Galai-3Gal disaccharide epitopes. Xenotransplantation. 1995, 2, 98
SANDRIN, M.S., VAUGHAN, H.A., DABKOWSKI, P.L., MCKENZIE, I.RC Antipig IgM antibodies in human serum react predominantly with Gal(ai-3)Gal epitopes. Proc. Natl. Acad. Sci. USA 1993, 90, 11391
GALILI, U. Interaction of the natural anti-Gal antibody with a-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunology Today. 1993, 14, 480
CAIRNS, T., KARLSSON, E., HOLGERSSON, J., et al. Confirmation of a major target epitope of human natural IgG and IgM anti-pig antibodies: terminal galactose α1,3galactose. Transplant. Proc. 1994, 26, 1384
CAIRNS, T., HAMMELMANN, W., GRAY, D., WELSH, K., LARSEN, G. Enzymatic removal from various tissues of the galactose α1,3galactose target antigens of human antispecies antibodies. Transplant. Proc. 1994, 26, 1279
FOURNIER, A.M., BIRCHALL, I.E., KYRIAZIS, A.G., PEARSE, M.J., D’APICE, A.J.F. A human naturally-occurring antibody, anti-Gal, recognizes epitopes in pig kidney, heart and liver and is cytotoxic to endothelial cells in the presence of rabbit complement. Second International Congress on Xenotransplantation, Cambridge, U.K., 1993 (abstract 113), p. 142
KARLSSON, E., CAIRNS, T., HOLGERSSON, J., WELSH, K., SAMUELSSON, B.E. Pig- to-human xenotransplantation. Confirmation of a major target epitope of preformed human natural IgG and IgM anti-pig-terminal galactose α1,3galactose. Glycoconjugate J. 1993, 10, 297
WIESLANDER, J., MANSSON, O., KALLIN, E., et al. Specificity of human antibodies against Gal α1–3Gal carbohydrate epitope and distinction from natural antibodies reacting with Gal α1–2Gal or Gal α1–4Gal. Glycoconjugate J. 1990, 7, 85
MINANOV, O., ITESCU, S., KWIATKOWSKI, P., et al. Preformed and induced anti-Gal cytotoxic antibodies in newborn humans and baboons. (Abstract) J. Heart Lung Transplant., 1996, 15, 101
GALILI, U., MANDRELL, R.E., HAMADEH, R.M., SHOHET, S.B., GRIFFISS, J.M. Interaction between the human natural anti- α-galactosyl Immunoglobulin G and bacteria of the human flora. Infect. Immun. 1988, 57, 1730
WELSH, K.I., TAUBE, D.H., THICK, M., et al. Human antibodies to pig determinants and their association with hyperacute rejection of xenografts. In: Xenotransplantation. (Cooper, D.K.C, et al., eds) Heidelberg, Springer, 1991, p. 501
GALILI, U., RACHMILEWITZ, E.A., PELEG, A., FLECHNER, I. A unique natural human IgG antibody with anti- α-galactosyl specificity. J. Exp. Med. 1984, 160, 1519
GALILI, U, CLARK, M.R., SHOHET, S.B., BUEHLER, J., MACHER, B.A. Evolutionary relationship between the natural anti-Gal antibody and the Gal α1–3Gal epitope in pri- mates. Proc. Natl. Acad. Sei. USA. 1987, 84, 1369
GALILI, U, SHOHET, S.B., KOBRIN, E., STULTS, C.L.M., MACHER, B.A. MAN, apes and Old World monkeys differ from other mammals in the expression of a-galactosyl epitopes on nucleated cells. J. Biol. Chem. 1988, 263, 17755
JOZIASSE, D.H., SHAPER, J.H., JABS, E.W., SHAPER, N.L. Characterization of an aGah-3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed psdeudogene. J. Biol. Chem. 1991, 266, 6991
LARSEN, R.D., RIVERA-MARRERO, CA., ERNST, L.K., CUMMINGS, R.D., LOWE, J.B. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gα1:β-D-Gal(1–4)-D-GlcNAca(1–3)-galactosyl transferase cDNA. J. Biol. Chem. 1990, 265, 7055
GALILI, U. The natural anti-Gal antibody: evolution and autoimmunity in man. Immunol. Series. 1991, 55, 355
ORIOL, R., YE, Y., KOREN, E., COOPER, D.K.C. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation. 1993, 56, 1433
ORIOL, R., BARTHOD, R, BERGEMER, A-M, et al. Monomorphic and polymorphic carbohydrate antigens on pig tissues: implications for organ xenotransplantation in the pig-to-man model. Transplant. Int. 1994, 7, 405
BACKER, A.E., HOLGERSSON, J., KARLSSON, H., BINNS, R.M., SAMUELSSON, B.E. (1993) Structural characterization of glycosphingolipids in different organs of a semi-inbred pig strain using GC/MS of ceramide glycanase-released oligosaccharides. Second International Congress on Xenotransplantation. Cambridge, U.K. (abstract 24) p. 52
RYDBERG, I., CAIRNS, T.D.H., GROTH, CG., et al. Specificities of human IgM and IgG anticarbohydrate xenoantibodies found in the sera of diabetic patients grafted with fetal pig islets. Xenotransplantation. 1994, 1, 69
CAIRNS, T., LEE, J., GOLDBERG, L., et al. Polymorphism within the human IgG anti- pig repertoire. (Abstract) Presented to the British Transplantation Society. Manchester, U.K., 1995
KOREN, E., NEETHLING, RA., KOSCEC, M., et al. In vitro model for hyperacute rejection of xenogeneic cells. Transplant. Proc. 1994, 26, 1166
NEETHLING, RA., KOREN, E., YE, Y., et al. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by a-galactosyl oligosaccharides. Transplantation. 1994, 57, 959
LAVECCHIO, J.A., DUNNE, A.D., EDGE, A.S.B. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. Transplantation. 1995, 68, 841
NEETHLING, R, JOZIASSE, D., BOVIN, N., et al. The reducing end of aGal oligosaccharides contributes to their efficiency in blocking natural antibodies of human and baboon sera. Transplant. Int. 1996, 9, 98
YE, Y., NEETHLING, F.A., NIEKRASZ, M., et al. Intravenous administration of α-galactosyl carbohydrates reduces in vivo baboon serum cytotoxicity to pig kidney cells and transplanted pig hearts. Transplant. Proc. 1994, 26, 1399
YE, Y., NEETHLING, RA., NIEKRASZ, M., et al. Evidence that intravenously administered α-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation. 1994, 58,330
TANIGUCHI, S., NEETHLING, RA., BOVIN, N., et al. In vivo immunoadsorption of anti-pig antibodies in baboons using a specific aGah-3Gal column. Transplantation. In press
COOPER, D.K.C, KOREN, E., ORIOL, R. Manipulation of the anti-aGal antibody-aGal epitope system in experimental discordant xenotransplantation. Xenotransplantation. 1996, 3, 102
ZHAO, Z., MICHALSKI, J.C, CHEREAU, C, et al. An approach to the structure of carbohydrate epitopes recognized by human natural antibodies on porcine endothelial cells. Transplant. Proc. 1994, 26, 1390
LI, S.F., YEH, J-C, COOPER, D.K.C, CUMMINGS, R.D. Inhibition of human anti-aGal IgG by oligosaccharides derived from porcine stomach mucin. Xenotransplantation. 1995, 2, 279
LI, S.R, NEETHLING, RA., YEH, J-C, COOPER, D.K.C. Potent inhibition of human and baboon anti-aGal antibodies by a subfraction of oligosaccharides derived from porcine stomach mucin. Transplant. Proc. 1996, 28, 558
LI, S.R, NEETHLING, RA., TANIGUCHI, S., et al. Glycans derived from porcine stomach mucin are effective inhibitors of natural anti-aGal antibodies in vitro and in vivo. Transplantation. In press
GLENISTER, D.A., SALAMON, K.E., SMITH, K., BEIGHTON, D., KEEVIL, C.W. Enhanced growth of complex communities of dental plaque bacteria in mucin-limited continuous culture. Microbiol. Ecol. in Health and Dis. 1988, 1, 31
INVERARDI, L., SAMAJA, M., MARELLI, E, BENDER, J.R., PARDI, R. Cellular immune recognition of xenogeneic vascular endothelium. Transplant. Proc. 1992, 24, 459
LEVENTHAL, J.R., DALMASSO, A.P., CROMWELL, J.W., et al., Prolongation of cardiac xenograft survival by depletion of complement. Transplantation. 1993, 55, 857
REDING, R., WHITE, D.J.G., DAVIES, H.H.S., et al. Effect of splenectomy on antibody rebound after plasma exchange. Transplantation. 1989, 48, 145
COOPER, D.K.C, KOREN, E., ORIOL, R. Genetically engineered pigs. Lancet. 1993, 342, 682
DABKOWSKI, P.L., VAUGHAN, H.A., MCKENZIE, I.F.C, SANDRIN, M.S. Characterization of a cDNA clone encoding the pig ai,3galactosyltransferase: implications for xenotransplantation. Transplant. Proc. 1993, 25, 2921
LARSEN, R.D., RAJAN, V.P., RUFF, M., et al. Isolation of a cDNA encoding murine UDP galactose: β-D-galactosyl–1,4-N-acetyl-D-glucosaminide α-1,3-galactosyltransferase: Expression cloning by gene transfer. Proc. Natl. Acad. Sci. USA. 1989, 86, 8227
LOWE, J.B., LARSEN, R.D., RUFF, M.M., CUMMINGS, R.D. Isolation of cloned cDNAs that direct expression of oligosaccharides recognized by Griffonia simplicifolia isolectin B4. J. Cell. Biochem. 1989, 13A, 129
JOZIASSE, D.H., SHAPER, J.H., VAN DEN EIJNDEN, D.H., et al. Bovine α1-3 galactosyltransferase: isolation and characterization of a cDNA clone. Identification of homo- logous sequences in human genomic DNA. J. Biol. Chem. 1989, 264, 14290
SANDRIN, M.S., FODOR, W.L., MOUHTOURIS, E., et al. Enzymatic remodeling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody bind- ing and complement-mediated cytolysis. Nature Med. 1995, 1, 1248
BISHOP, D.F., CALHOUN, D.H., BERNSTEIN, H.S., et al. Human a-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme. Proc. Natl. Acad. Sei. USA. 1986, 83, 4859
DEN HERDER, I.F., MATEO ROSELL, A.M., VAN ZUILEN, CM., PUNT, P.J., VEN DEN HONDEL, CA.M.J.J. Cloning and expression of a member of the Aspergillus niger gene family encoding agalactosidase. Mol. Gen. Genet. 1992, 233, 404
ZHU, A., GOLDSTEIN, J. Cloning and functional expression of a cDNA encoding cof- fee bean α-galactosidase. Gene. 1994, 140, 227
LIM, CS., CHAPMAN, G.D., GAMMON, R.S., et al. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation. 1991, 83, 2007
ARDEHALI, A., FYFE, A., LAKS, H., et al. (1995) Direct gene transfer into donor hearts at the time of harvest. J. Thorac. Cardiovasc. Surg. 1995, 109, 716
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Neethling, F.A. et al. (1997). Roles of Anti-αGal Antibody and Oligosaccharide Therapy in Xenotransplantation. In: Cooper, D.K.C., Kemp, E., Platt, J.L., White, D.J.G. (eds) Xenotransplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60572-7_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-60572-7_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64460-3
Online ISBN: 978-3-642-60572-7
eBook Packages: Springer Book Archive